This trial is for patients who have cancer cells still in the blood or bone marrow after approximately one year of lenalidomide maintenance therapy following a stem cell transplant
Dr. Michael Atkins, a medical oncologist who specializes in melanoma, talks about the results of the DREAMseq trial and how the information will hopefully extend life for more patients with advanced melanoma
A screening study is one that tests new ways to find disease early; a surveillance study investigates methods to monitor an unusual finding – such as a cyst or mole – that may or may not turn into cancer. This issue explores several such trials in breast and pancreas cancers.